The discovery of this novel association between COL1A1 expression and survival could have implications in the management of ILDs, as BAL and COL1A1 measurement could act as a biomarker of progression at the initial stages of the ILD diagnosis. The gene discussed is COL1A1; the disease is interstitial lung disease.